Skip to main content
    H

    Hyperfine Inc (HYPR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.61
    -0.02 (-3.05%)

    Market Cap: $66.74M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Hyperfine Inc (HYPR) Financials: Revenue, Profit and Cash Flow

    Updated Nov 9, 2026. Financial statements from company filings, amounts in US dollars.

    Hyperfine reported revenue of $13.56M for the fiscal year ended Dec 31, 2025, up 5.2% from the year before. That year, net income was -$35.57M with a net margin of -262.3%, operating cash flow was -$27.95M and free cash flow was -$29.13M. The quarter ended Sep 30, 2026 had revenue of $5.96M and net income of -$5.98M.

    Revenue and Margins

    Over the 5 years to Dec 2025, revenue grew from $294.00K, a compound annual rate of 115.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$13.56M+5.2%49.8%-273.4%-262.3%
    Dec 2024$12.89M+16.8%45.7%-335.3%-315.9%
    Dec 2023$11.03M+61.9%43.1%-436.1%-401.0%
    Dec 2022$6.81M+355.5%13.3%-1084.2%-1073.7%
    Dec 2021$1.50M+408.8%-78.0%-4336.1%-4335.0%
    Dec 2020$294.00KN/A-162.2%-7990.1%-7968.4%
    Dec 2019$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$13.56M$12.89M$11.03M$6.81M$1.50M$294.00K$0
    Cost of revenue$6.81M$7.00M$6.28M$5.91M$2.66M$771.00K$0
    Gross profit$6.75M$5.89M$4.76M$907.00K-$1.17M-$477.00K$0
    Research and development$17.45M$22.50M$22.49M$28.16M$25.84M$14.59M$13.39M
    Operating income-$37.09M-$43.22M-$48.12M-$73.87M-$64.87M-$23.49M-$19.97M
    Net income-$35.57M-$40.72M-$44.24M-$73.16M-$64.85M-$23.43M-$18.79M
    EBITDA-$35.51M-$42.20M-$47.03M-$72.91M-$64.14M-$23.21M-$19.83M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$5.96M$3.90M$3.90M$5.29M$3.44M$2.70M$2.14M$2.32M$3.64M$3.63M$3.29M$2.69M
    Gross profit$3.38M$1.98M$1.98M$2.69M$1.85M$1.33M$883.00K$826.00K$1.91M$1.80M$1.35M$1.03M
    Operating income-$7.26M-$8.47M-$8.56M-$7.67M-$8.92M-$9.60M-$10.90M-$10.77M-$10.96M-$10.85M-$10.65M-$11.63M
    Net income-$5.98M-$9.30M-$8.62M-$5.91M-$11.02M-$9.22M-$9.42M-$10.39M-$10.33M-$10.16M-$9.85M-$10.68M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $248.00K by $34.84M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$55.26M$58.90M$94.20M$134.05M$202.47M$71.53M$30.57M
    Current assets$50.91M$53.71M$88.91M$128.66M$197.49M$68.33M$27.96M
    Cash and equivalents$35.09M$37.65M$75.18M$117.47M$188.50M$62.68M$26.44M
    Total liabilities$14.26M$9.86M$9.80M$10.33M$16.25M$4.29M$1.79M
    Short-term debt$248.00K$269.00K$185.00KN/A$10.08M$1.38MN/A
    Long-term debt$0N/AN/AN/A$0$178.00KN/A
    Shareholder equity$41.01M$49.04M$84.40M$123.72M$186.23M-$61.05M$28.78M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$57.79M$63.00M$60.34M$55.26M$41.51M$45.23M$53.38M$58.90M$69.39M$76.61M$85.44M$94.20M
    Total liabilities$26.05M$26.24M$25.98M$14.26M$14.64M$10.11M$10.26M$9.86M$11.06M$9.85M$9.80M$9.80M
    Cash and equivalents$37.87M$43.46M$40.78M$35.09M$21.56M$25.42M$33.09M$37.65M$45.77M$53.81M$63.20M$75.18M
    Shareholder equity$31.74M$36.76M$34.36M$41.01M$26.87M$35.13M$43.11M$49.04M$58.32M$66.76M$75.64M$84.40M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow-$27.95M-$38.77M-$41.81M-$72.34M-$47.18M-$21.52M-$18.37M
    Capital expenditures$1.19M$383.00K$804.00K$585.00K$2.71M$1.57M$244.00K
    Free cash flow-$29.13M-$39.15M-$42.61M-$72.92M-$49.89M-$23.09M-$18.62M
    Share repurchasesN/AN/AN/AN/A$7.00K$129.00KN/A
    Investing cash flow-$1.19M-$383.00K-$804.00K-$585.00K-$2.71M-$1.57M-$244.00K
    Financing cash flow$27.50M$1.02M$174.00K$7.00K$176.77M$60.94M$4.74M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$6.08M-$7.27M-$9.01M-$5.21M-$5.58M-$7.91M-$9.25M-$8.36M-$8.52M-$9.38M-$12.51M-$9.94M
    Capital expenditures$21.00K$30.00K$242.00K$63.00K$130.00K$520.00K$472.00K$8.00K$159.00K$71.00K$145.00K$258.00K
    Free cash flow-$6.10M-$7.30M-$9.25M-$5.27M-$5.71M-$8.43M-$9.72M-$8.37M-$8.68M-$9.45M-$12.65M-$10.20M
    Last 12 quarters

    Frequently Asked Questions About HYPR

    What is Hyperfine's annual revenue?

    Hyperfine reported revenue of $13.56M for the fiscal year ended Dec 31, 2025.

    How fast is Hyperfine's revenue growing?

    Revenue was up 5.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 25.8%.

    Is Hyperfine profitable?

    No. Hyperfine reported net income of -$35.57M for the fiscal year ended Dec 31, 2025, with a net margin of -262.3%.

    How much free cash flow does HYPR generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$27.95M minus capital expenditures of $1.19M produced free cash flow of -$29.13M.

    How much debt does Hyperfine have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $0, short-term debt of $248.00K and cash and equivalents of $35.09M.